Citius Pharma (CTXR) Brings More Experts on Board CTXR looking ready to hit the gas Good day everyone, We are continuing our coverage of Citius Pharma...
Late Stage Biotech Citius Pharma (NASDAQ: CTXR) Golden Cross Chart, Recent News and Phase III
Citius Pharma (NASDAQ: CTXR) FDA review data from the phase III trial of MIno-Lok may be a major catalyst for the company shares
Citius Pharmaceuticals (NASDAQ: CTXR) Positive Phase 3 Data, $1.5B Global Market, Trading Below Book, Full Research Report
The positive data from this analysis is a big milestone for Citius Pharma (NASDAQ: CTXR) and could act as a catalyst for the company’s shares.